[HTML][HTML] Exploring tumor heterogeneity using PET imaging: the big picture

C Bailly, C Bodet-Milin, M Bourgeois, S Gouard… - Cancers, 2019 - mdpi.com
Personalized medicine represents a major goal in oncology. It has its underpinning in the
identification of biomarkers with diagnostic, prognostic, or predictive values. Nowadays, the …

Actinium-225 Targeted Agents: Where Are We Now?

F Mourtada, K Tomiyoshi, J Sims-Mourtada… - Brachytherapy, 2023 - Elsevier
ABSTRACT α-particle targeted radionuclide therapy has shown promise for optimal cancer
management, an exciting new era for brachytherapy. Alpha-emitting nuclides can have …

[HTML][HTML] Combination of [177Lu]Lu-DOTA-TATE Targeted Radionuclide Therapy and Photothermal Therapy as a Promising Approach for Cancer Treatment: In Vivo …

M Simón, JT Jørgensen, HA Khare, C Christensen… - Pharmaceutics, 2022 - mdpi.com
Peptide receptor radionuclide therapy (PRRT) relies on α-and β-emitting radionuclides
bound to a peptide that commonly targets somatostatin receptors (SSTRs) for the localized …

Assessment of DNA/RNA Deregulation in Cancer Using 99mTc-Labeled Thiopurine

CH Chiu, DJ Yang, YC Liou, WC Chang… - Cancer Biotherapy & …, 2024 - liebertpub.com
Background: DNA biomarkers are useful for the assessment of tumor cell proliferation. The
authors aimed to synthesize a thiopurine-based ligand for evaluation of nuclear uptake and …

Improving outcomes in carcinoid heart disease–learning from a single centre

J Cope, R Maclean, S Hota, JK Ramage… - Nuclear Medicine …, 2023 - journals.lww.com
Results Twenty-six patients underwent valve replacement. Mean (SD) age was 61 (11)
years, 54% female. Eleven tumours were grade G1, with the remaining G2. NYHA pre …

Studies on batch formulation of a freeze dried kit for the preparation of 99mTc-HYNIC-TATE for imaging neuroendocrine tumors

A Mukherjee, A Korde, A Shinto, HD Sarma… - Applied Radiation and …, 2019 - Elsevier
Aim To formulate freeze dried cold kits for preparation of 99m Tc-HYNIC-TATE suitable for
use at hospital radiopharmacy and establish clinical utility of 99m Tc-HYNIC-TATE prepared …

[HTML][HTML] Evaluation of dosimetric parameters for tumor therapy with 177Lu and 90Y radionuclides in gate Monte Carlo code

M Peer-Firozjaei, MA Tajik-Mansoury… - Journal of Biomedical …, 2021 - ncbi.nlm.nih.gov
Background: 90 Y and 177 Lu are two well-known radionuclides used in radionuclide
therapy to treat neuroendocrine tumors. Objective: This current study aims to evaluate …

Novel radiation-activated Photodynamic Therapy (radioPDT) Theranostic Nanoparticle for Treatment of Deep-seated Tumors

D Dinakaran - 2020 - era.library.ualberta.ca
Radiotherapy is used in the treatment of 50% of all cancer patients. It has evolved into a high
precision therapy in cancer care. Radiotherapy's main limitation is the damage incurred on …

[HTML][HTML] Immunhistochemische Analyse der Expression von mTOR-Pfadweg-Komponenten in Neuroendokrinen Tumoren des Magens

K Griniak - 2021 - refubium.fu-berlin.de
Der “mammalian target of rapamycin”(mTOR) ist ein bedeutsamer Regulator der
Zellproliferation und Proteintranslation. Bei einer Vielzahl von Malignomen ist mTOR …